Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benzodiazepine-ketamine versus benzodiazepine-fentanyl sedation for cataract surgery
RBR-7c4c5jxPhase 3Not yet recruiting
- Sponsor
- Hospital Oftalmológico de Brasília
- Start
- Oct 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketamine, fentanyl and midazolam in cataract, sponsored by Hospital Oftalmológico de Brasília. Primary endpoint: Pain during surgery. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
ketaminefentanylmidazolam
03
Conditions
cataract
Beyond the preview
Go deeper on RBR-7c4c5jx.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7c4c5jx.